SOURCE: Industrial Info Resources
April 14, 2008 06:00 ET
Alexion Pharmaceutical Hopes the Fourth Time Is a Charm for Smithfield Site, an Industrial Info News Alert
SUGAR LAND, TX--(Marketwire - April 14, 2008) - Reported by Annette Kreuger, Industrial Info
Resources (Sugar Land, Texas) -- The most recent incarnation of the former
Dowpharma (NYSE:DOW) (Midland, Michigan) plant in Smithfield, Rhode
Island, is now complete. Alexion Pharmaceuticals (NASDAQ:ALXN) (Cheshire,
Connecticut) has made a capital investment of $80 million into renovating
the 60,000-square-foot plant for the production of its blood disorder drug,
Soliris. The company is hoping it will fare better than the 15-year-old
site's previous three owners, all of whom watched their ambitious plans
turn to dust.
For details, view the entire article by subscribing to Industrial Info's
Premium Industry News at
http://www.industrialinfo.com/showNews.jsp?newsitemID=131161, or browse
other breaking industrial news stories at www.industrialinfo.com.
Industrial Info Resources (IIR) is a marketing information service
specializing in industrial process, energy and financial related markets
with products and services ranging from industry news, analytics,
forecasting, plant and project databases, as well as multimedia services.
For more information send inquiries to email@example.com or
visit us at www.industrialinfo.com.